Cancer Res 2005, 65:2296–2302.PubMedCrossRef
24. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, https://www.selleckchem.com/products/ulixertinib-bvd-523-vrt752271.html Richmond A, Lin PC, Moses HL: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid www.selleckchem.com/products/Staurosporine.html cells that promote metastasis. Cancer Cell 2008, 13:23–35.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions KI did animal experiments, flow cytometry work, and analyzed data and wrote the paper. YM designed the research. SK and TS made TGF-β1 transfected SCCVII cell line. MI, HS, YS and SM performed contributed data analysis. JO contributed experimental design and data analysis. All authors read and approved the final manuscript.”
“Introduction Breast cancer is a major malignant tumor threatens women’s health. It is the second leading cause to women’s death [1].
Ulinastatin (UTI), a physiological urinary trypsin inhibitor, inhibits a variety of proteases. It is widely Selleck SIS 3 used in treatment of inflammatory diseases, including disseminated intravascular coagulation, shock, and pancreatitis [2, 3]. Our previous study showed that UTI exerts significant inhibitory effects on 1) the proliferation and invasion of human breast cancer cell lines MCF-7 and MDA-MB-231, 2) the growth of MCF-7 transplanted tumor in nude mice, 3) the gene and protein expression of CXCR4 and MMP-9 in breast cancer cells; UTI also enhances the anti-tumor
effect of the chemotherapy drug cyclophosphamide [4, 5]. TXT is the most effective chemotherapy drug to treat breast cancer. It is widely used on the treatment of metastatic breast cancer. In addition, it is a novel adjuvant chemotherapy for breast cancer patients [6]. In this study, we detected the inhibitory mechanisms of UTI on breast carcinoma growth via observations in in vivo and in vitro experiment of effects of UTI and TXT on the expression of human breast cancer cell lines, xenografted tumor, and insulin-like growth factor receptor 1 (IGF-1R), platelet-derived growth factor A (PDGFA), nerve growth factor (NGF). 1. Materials and methods 1.1 Cell line and animals Human breast cAMP cancer cell line MDA-MB-231 (ER-) was a generous gift from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The total 95 female BALB/c nu/nu mice aged 4-6 weeks old and weighing 17-21 g were provided by Chongqing Medical University Animal Research Center (Production License No. SCXK [Beijing] 2005-0013; Usage Permission No. SYX [Chongqing] 2007-0001). 1.2 Major reagents and apparatus UTI was a generous gift from Techpool Bio-Pharma (Guangzhou, China); TXT was a generous gift from Sanofi-Aventis. The RT-PCR kit was purchased from TAKARA. Anti-IGF-1R antibody and anti-PDGFA antibody were purchased from Bioworld Technology (USA).